KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Cme (CME) Net Income towards Common Stockholders (2016 - 2025)

Cme (CME) has disclosed Net Income towards Common Stockholders for 17 consecutive years, with $1.2 billion as the latest value for Q4 2025.

  • On a quarterly basis, Net Income towards Common Stockholders rose 35.23% to $1.2 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $4.0 billion, a 15.5% increase, with the full-year FY2025 number at $4.0 billion, up 15.5% from a year prior.
  • Net Income towards Common Stockholders was $1.2 billion for Q4 2025 at Cme, up from $896.6 million in the prior quarter.
  • In the past five years, Net Income towards Common Stockholders ranged from a high of $1.2 billion in Q4 2025 to a low of $510.3 million in Q2 2021.
  • A 5-year average of $798.1 million and a median of $824.4 million in 2023 define the central range for Net Income towards Common Stockholders.
  • Peak YoY movement for Net Income towards Common Stockholders: skyrocketed 125.15% in 2021, then dropped 27.57% in 2022.
  • Cme's Net Income towards Common Stockholders stood at $605.9 million in 2021, then increased by 3.98% to $630.0 million in 2022, then rose by 27.67% to $804.3 million in 2023, then grew by 7.39% to $863.7 million in 2024, then skyrocketed by 35.23% to $1.2 billion in 2025.
  • Per Business Quant, the three most recent readings for CME's Net Income towards Common Stockholders are $1.2 billion (Q4 2025), $896.6 million (Q3 2025), and $1.0 billion (Q2 2025).